Minnesota FOIA #P0102629R1

Elimination of B Cells in Systemic Lupus Erythematosus Using an Engineered yo CAR T cell

This purchase order from the Twin Cities government agency awards Luminary Therapeutics Inc a contract valued at $385,000 for the development and supply of engineered CAR T cells aimed at eliminating B cells in patients with systemic lupus erythematosus. The order was issued on March 14, 2024, and involves a single lot of the specified therapeutic product. The award emphasizes a specialized biomedical research and treatment service, with Luminary Therapeutics Inc serving as the vendor. The contract appears to be a one-time procurement for a specific project or research initiative, with no mention of a multi-year or blanket arrangement.

Description

Elimination of B Cells in Systemic Lupus Erythematosus Using an Engineered yo CAR T cell